Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
Just nowAppendix 4C and Quarterly Activities Report - March 2026
14m agoLandis+Gyr Announces Sale of Rhebo to Everfield
14m agoLazard to Acquire Campbell Lutyens, Creating the Global Leader in Private Capital Advisory
24m ago2026 ESMO GC | Mabwell to Present Latest Clinical Data on 9MW2821 for Cervical Cancer in Oral and Poster Presentations
36m agoHaier Biomedical Drives Global Leap of Life Science Infrastructure: International Business Hits Record High for 36% of Annual Revenue in 2025
Veru Inc logo

Veru Inc

About

Veru Inc (NASDAQ:VERU) — investor relations, events, news, and company updates on 6ix.

Latest News

Mar 9 2026
Veru Enrolls First Patient in Phase 2b PLATEAU Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss
Feb 19 2026
Veru to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
Feb 11 2026
Veru Reports Fiscal 2026 First Quarter Financial Results and Clinical Program Progress
Feb 4 2026
Veru to Report Fiscal 2026 First Quarter Financial Results on February 11th
Dec 17 2025
Veru Reports Fiscal Year 2025 Financial Results and Clinical Program Progress

Financials

Revenue
$16.89 M
Market Cap
$39 M
EPS
-1.21

Community Chat

Ask AI

6ix6ix